{"product_id":"ma-321","title":"Anti-Human MIP-2 beta, IgG Fraction, Monoclonal","description":"\u003cp\u003eAnti-human MIP-2 beta IgG fraction (IgGl) is a monoclonal antibody raised against purified human recombinant MIP-2 beta. The antigen was produced in genetically engineered yeast, and purified by sequential chromatography. The monoclonal antibody was purified using Protein G.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This monoclonal antibody recognizes recombinant human MIP-2 beta by Western analysis (1\/100 dilution) and ELISA. This antibody is very specific for MIP-2 beta, presenting a slight cross reactivity with MIP-2 alpha, but no other MIP proteins.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e IgG (IgG1) fraction. 100 µg (500 µL). Frozen liquid. 0.20 mg\/mL Formulated in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Wolpe, S.D. et al (1989) The FASEB Journal, 3, 2565-2573.\u003cbr\u003e2. Sherry, B et al (1988) J. Exp. Med. 168, 2251-2259.\u003cbr\u003e3. Wolpe, S.D. et al (1988) J. Exp. Med. 167, 570-581.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518880510254,"sku":"MA-321-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-ma-321-100ug.png?v=1788008325","url":"https:\/\/www.australbiologicals.com\/products\/ma-321","provider":"Austral Biologicals","version":"1.0","type":"link"}